Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 7
2015 5
2016 11
2017 11
2018 10
2019 6
2020 11
2021 13
2022 11
2023 5
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Conduction disorders following transcatheter aortic valve replacement using acurate Neo2 transcatheter heart valve: A propensity matched analysis.
Loewenstein I, Finkelstein A, Banai S, Halkin A, Konigstein M, Ben-Shoshan J, Arbel Y, Barbash I, Segev A, David P, Elbaz-Greener G, Assa-Vaknin H, Kornowski R, Dvir D, Asher E, Steinvil A. Loewenstein I, et al. Among authors: konigstein m. Cardiovasc Revasc Med. 2024 May 5:S1553-8389(24)00460-3. doi: 10.1016/j.carrev.2024.05.002. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38719632
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Apr 17:e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 38629312
Reintervention After TAVR vs SAVR: A Self-Expanding Experience.
Ben-Shoshan J, Finkelstein A, Konigstein M. Ben-Shoshan J, et al. Among authors: konigstein m. JACC Cardiovasc Interv. 2024 Apr 22;17(8):1017-1019. doi: 10.1016/j.jcin.2024.02.027. Epub 2024 Apr 3. JACC Cardiovasc Interv. 2024. PMID: 38573258 No abstract available.
Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk.
Kornowski R, Konigstein M, Jonas M, Assali A, Vaknin-Assa H, Segev A, Danenberg H, Halabi M, Roguin A, Kerner A, Lev E, Karamasis GV, Johnson TW, Anderson R, Blaxill J, Jadhav S, Hoole S, Witberg G, Issever MO, Ben-Yehuda O, Baumbach A. Kornowski R, et al. Among authors: konigstein m. J Am Heart Assoc. 2024 Jan 16;13(2):e029051. doi: 10.1161/JAHA.122.029051. Epub 2024 Jan 12. J Am Heart Assoc. 2024. PMID: 38214256 Free PMC article. Clinical Trial.
Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
Arow Z, Konigstein M, Vaknin-Assa H, Witberg G, Jonas M, Kerner A, Cafri C, Rubinshtein R, Segev A, Roguin A, Issever MO, Gabarin M, Pereg D, Assali A, Koifman E. Arow Z, et al. Among authors: konigstein m. Catheter Cardiovasc Interv. 2024 Jan;103(1):61-67. doi: 10.1002/ccd.30924. Epub 2023 Dec 14. Catheter Cardiovasc Interv. 2024. PMID: 38098249 Clinical Trial.
Impact of Complete Revascularization in the ISCHEMIA Trial.
Stone GW, Ali ZA, O'Brien SM, Rhodes G, Genereux P, Bangalore S, Mavromatis K, Horst J, Dressler O, Poh KK, Nath RK, Moorthy N, Witkowski A, Dwivedi SK, Bockeria O, Chen J, Smanio PEP, Picard MH, Chaitman BR, Berman DS, Shaw LJ, Boden WE, White HD, Fremes SE, Rosenberg Y, Reynolds HR, Spertus JA, Hochman JS, Maron DJ; ISCHEMIA Research Group. Stone GW, et al. J Am Coll Cardiol. 2023 Sep 19;82(12):1175-1188. doi: 10.1016/j.jacc.2023.06.015. Epub 2023 Jul 17. J Am Coll Cardiol. 2023. PMID: 37462593 Clinical Trial.
86 results